法国国家健康与医学研究院是法国国家级医学研究机构，法国国家健康与医学研究院（法文为：Institute national de la santé et de la recherche médicale），简称“Inserm”，成立于1964年，是一所总部位于法国巴黎的国家级公共科学和技术研究机构，其前身是成立于1941年的法国国家卫生研究院，由法国卫生部和研究部共同管理。

Inserm是法国唯一一个完全致力于人类健康的公共研究组织 ，参与从研究到治疗的全过程，其宗旨通过增进对生命和疾病的知识、创新治疗方法和公共卫生研究，促进全人类健康   。

Inserm致力于利用生物医学手段研究人类健康，研究内容涉及临床医学和基础医学的50余个学科，同时与世界顶尖研究机构开展合作。Inserm总部设在法国巴黎，拥有13家地区性办公室，9家主题研究所 。

Inserm每年的文献产出量接近11,000余份，是欧洲第一大生物医学研究机构 ，在世界同类机构中位居第二（第一为美国国立卫生研究院）。它也是欧洲第一大专利注册生物医学学术研究实体，拥有超1,800余份专利 。在2016年汤森路透世界最具创新能力的公共研究机构排名中位居世界第10 。

Inserm在法国拥有281家研究单位、36家临床诊疗中心及34家服务单位，它也拥有29家附属国际/欧洲实验室  。其员工总数为8,100余名，包括2,100余名全职研究人员 ，年度经费预算约9亿欧元 。此外Inserm也拥有两位诺贝尔奖得主，3位拉斯克奖得主  。

Inserm成立于1964年，是一个由法国卫生部和研究部联合管理的公共科学和技术研究院。该研究所致力于生物医学研究和人类健康，并参与从研究到治疗的全过程。它还与世界上最负盛名的研究机构合作，致力于医学及健康领域的科学挑战和进步。

Inserm的15,000名研究人员、工程师、技术人员和行政人员围绕一个共同目标聚集在一起，即通过增进对生命和疾病的知识、创新治疗方法和公共卫生研究，改善全人类的健康。

为了尽可能有效地服务其宗旨，Inserm在法国和国外建立了超过350个研究机构，大多数是联合研究单位。其中一些单位更侧重于转化和临床研究（CIC），其他则向科学界提供高水平的技术服务和资源。

French national medical research institute.French National Institute of Health and Medical Research (French: Institute national de la sante et de la recherche medicale (Inserm), founded in 1964, is a national public scientific and technological research institute headquartered in Paris, France. Its predecessor is the French National Institute of Health, established in 1941, which is jointly managed by the French Ministry of Health and the Ministry of Research.

Inserm is the only public research organization in France fully committed to human health. It is involved in the whole process from research to treatment. Its aim is to promote the health of all mankind by improving knowledge of life and disease, innovative treatments and public health research.
Inserm is committed to biomedical research into human health, covering more than 50 disciplines in clinical medicine and basic medicine, and collaborating with the world's leading research institutions. Inserm is headquartered in Paris, France, with 13 regional offices and 9 thematic institutes.

With an annual output of nearly 11,000 articles, Inserm is the largest biomedical research institution in Europe and the second largest of its kind in the world (the first is the National Institutes of Health in the United States). It is also the largest biomedical academic research entity in Europe with more than 1,800 patents. It is ranked the 10th most innovative public research institution in the world by Thomson Reuters 2016.
Inserm has 281 research units, 36 clinical centres and 34 service units in France. It also has 29 affiliated international/European laboratories. It employs more than 8,100 people, including 2,100 full-time researchers, and has an annual budget of around 900 million euros. Inserm also has two Nobel Prize winners and three Lasker Prize winners.

Founded in 1964, Inserm is a public institute of science and technology jointly managed by the French Ministry of Health and the Ministry of Research. The Institute is dedicated to biomedical research and human health and is involved in the whole process from research to treatment. It also works with the world's most prestigious research institutions on scientific challenges and advances in medicine and health.

Inserm's 15,000 researchers, engineers, technicians and administrators come together around a common goal to improve the health of all humanity by advancing knowledge of life and disease, innovative treatments and public health research. [4]
Agency editor Broadcast
In order to serve its purpose as effectively as possible, Inserm has established more than 350 research institutes in France and abroad, most of them joint research units. Some of these units focus more on translational and clinical research (CIC), others provide a high level of technical services and resources to the scientific community.